B.O.S.S. Retirement Advisors LLC has invested a $1.69 million stake in IDEXX Laboratories. IDEXX Laboratories has launched a Cancer Dx Diagnostic Panel, set to benefit their stock (IDXX). The panel is part of a groundbreaking dog cancer detection test, set to be launched in 2025. Several institutions - Aegon Asset, SG Americas Securities, Manitou Investment, and Seilern Investment - have also modified their holdings in IDEXX. The firm has announced its Q4 and full-year 2024 earnings release for February 3rd. Despite the positive prospects, the market appears unsatisfied, causing the stock to decline.
IDEXX Laboratories has announced a massive 5 million share buyback program, expected to expand shareholder returns. A CFO transition has been announced. The Q3 earnings surpassed estimates, presenting a bull case theory. Despite a few institutions reducing their stock, most have increased their position, including RDA Financial Network and Legal Advantage Investments Inc. Analysts have given IDEXX Laboratories an average rating of 'Moderate Buy'.
Idexx Laboratories IDXX News Analytics from Wed, 01 May 2024 07:00:00 GMT to Sat, 25 Jan 2025 14:48:27 GMT - Rating 8 - Innovation 8 - Information 7 - Rumor 3
